Introduction
The dermatophyte Trichophyton rubrum is the main etiological agent of onychomycosis [1] [2] [3] . The conventional diagnosis of dermatophytosis is based on the recovery of the etiologic agent in culture and the subsequent microand macro-morphologic features of the colonies. However, the latter can take up to 4 weeks to develop [4] . Introduction of molecular-based diagnosis techniques enables a reduction of time needed for diagnosis to one working day [5, 6] . The multiplex PCR reaction described previously detects any dermatophyte DNA in the specimen and specifi cally T. rubrum DNA allowing its speciesidentifi cation [5] .
We subsequently developed an internal control in order to avoid false-negative results due to PCR inhibitors present in the specimens. We here report the results of the WO/2006/133701) DNA from nail specimens was released by a 10-min incubation of the sample in 100 μl of extraction buffer (60 mM sodium bicarbonate [NaHCO 3 ], 250 mM potassium chloride [KCl] and 50 mM Tris, pH 9.5) at 95°C and subsequent addition of 100 μl anti-PCR inhibition buffer (2% bovine serum albumin). After vortex mixing, 4 μl of this DNA-containing solution was used for identifi cation by multiplex PCR with 1 μM of the following primers: panDerm1 (5′ GAAGAAGATTGTCGTTTGCATCGTCTC 3′), panDerm2 (5′ CTCGAGGTCAAAAGCACGCCAGAG 3′) detecting a DNA fragment encoding chitin synthase 1, Trubrum-for (5′ TCTTTGAACGCACATTGCGCC 3′) and Trubrum-rev (5′ CGGTCCTGAGGGCGCTGAA 3′) detecting internal transcribed spacer 2 from T. rubrum, 1 μl of internal control (see below), 10 μl of PCR Ready Mix (Sigma, Germany) in a volume of 20 μl. The timetemperature profi le for PCR was 45 cycles of 30 s at 94°C, 30 s at 60°C, and 30 s at 72°C, preceded by initial denaturation for 10 min at 95°C. The presence of specifi c PCR products of approximately 366 bp (dermatophyte band), 203 bp (T. rubrum band) or 668 bp (internal control band) was examined using electrophoresis on a 1% agarose gel and staining with ethidium bromide. In case of the lack of any PCR products, the multiplex reaction was repeated as described above, but using 2 μl instead of 4 μl DNAcontaining solution.
Sample preparation and multiplex PCR (patent application

PCR internal control
In order to detect the presence of Taq DNA polymerase inhibitors or sub-optimal reaction conditions an internal process control (IPC) was constructed as previously described [7] . In brief, primers amplifying parts of the phage lambda genome were constructed including the sequence of each of the panDERM primers added to the 5′ end of the corresponding lambda specifi c primer (sequence in bold corresponds to the phage lambda sequence): IPCpanDERM366-for (5′ GAAGAAGATTGT CGTTTGCATCGTCTCCTGACGGTTTCTAAC 3′) and IPCpanDERM366-rev (5′ CTCGAGGTCAAAAGCACG CCAGAGGACATACGGAAATAG 3′). PCR products thus containing the binding sites of the panDERM primers on each side of the lambda phage sequence were obtained by amplifi cation of 1 ng purifed lambda DNA with an annealing temperature of 40°C. After gel-purifi cation of the amplicons, a 10-fold titration was performed and the dilution of the IPC, producing no increase in the detection-limit of purifi ed dermatophyte DNA, was used in the reaction.
Results
Dermatophytes were recovered from a total 22 (20.2%) of the specimens (15 or 68% of which were T. rubrum (Table 1 ). An additional 15 samples (13.8%) were microscopically positive but culture negative. This may represent culture negative dermatophyte infections, infection/ colonization with non-dermatophytes, and/or false positive microscopic results due to artifacts misinterpreted as fungal elements. Thus, 46.8% of the microscopy positive samples were negative by culture. Considering microscopy positive samples as true positives a total of 37/109 samples were positive (33.9%).
Using 4-μl DNA extracts from the samples for analysis by PCR, we found that (a) 35 (32.1%) of the samples were [1, 12] . Therefore, patients with clinical signs of onychomycosis but with negative PCR test on relevant specimens should subsequently be tested by microscopy and culture. Furthermore, this PCR test does not provide species identifi cation of dermatophytes other than T. rubrum. In most countries, however, T. rubrum is the predominant species and Microsporum spp. are very rarely encountered in tinea unguium and athlete's foot. Thus appropriate treatment, which varies by genus, can be initiated even for dermatophyte positive but T. rubrum negative samples. However, for epidemiological purposes we routinely culture these samples (approximately 9% of all samples) in order to provide the species identifi cation.
As shown in Table 1 , PCR was negative for two samples that were culture positive for T. rubrum and one that was positive for T. mentagrophytes. A likely reason for these false negative results is that they represent an artifact of the nail specimens being divided between conventional and molecular testing, and where, by chance alone, positive material was not included in the subsample set aside for molecular testing. The sampling is destructive and this idea cannot be directly tested, but such problems with sample division have long been a known factor in dermatologic mycology testing. Especially as on the other hand fi ve microscopy and culture negative samples were PCR positive (all T. rubrum), insuffi cient sensitivity of the molecular testing is not likely the reason.
In conclusion, despite some limitations this routine evaluation of the 5-hour multiplex PCR test, including inhibition control, demonstrates that the test is robust and can be easily run in a routine laboratory with markedly reduced time to diagnosis and higher sensitivity as obvious advantages.
positive for either T. rubrum or a dermatophyte other than T. rubrum, (b) 68 (62.3%) samples were negative and (c) six were inhibited (5.5%, Table 1 ). Repeating these six samples with a smaller amount of template (2 μl, instead of 4 μl DNA) allowed for detection of dermatophyte DNA in two samples (both microscopy positive) and confi rmed negative results obtained by conventional diagnostic methods for the remaining four specimens. Thus, in total, 37 samples (33.9%) were found to be positive by PCR analysis. T. rubrum was detected in 27 (73.0% of the PCR positive samples, 25% of all samples) and a dermatophyte other than T. rubrum in 10 samples (27.0% of the PCR positive samples, 9% of all samples). In 5 (4.6%) cases the PCR was positive for T. rubrum despite negative microscopy and culture, and in 2 (1.8%) cases the PCR was negative despite positive culture. In the majority of samples that were positive by PCR, but negative by culture, microscopic studies were positive (11/16, 68.8%). Furthermore only 5/72 culture and microscopy negative samples were positive by PCR (6.7%) while the PCR positivity rate was much higher among microscopic positive but culture negative samples 11/15 (73.3%).
Discussion
The results of these studies demonstrate that in a routine setting the PCR test is as sensitive as traditional diagnostic methods performed in a mycology reference laboratory if microscopic positive but culture negative samples are considered as true positives (33.9% positive by both tests). However, PCR is far more sensitive if only culture positive samples are considered true positives as is the practice in Nordic countries. If we consider samples that were microscopically positive but culture negative as true positives as is the practice in the UK and US, then PCR increased the proportion of samples for which the presence of a dermatophyte was confi rmed from 20.1% to 32.1% and the proportion of samples with species identifi cation from 20.1% to 24.8%. The introduction of an internal control demonstrated that 5% of the samples contained PCR inhibitors but this was overcome by rerunning these samples with a 50% reduction of DNAcontaining solution.
Another signifi cant advantage of the dermatophyte multiplex PCR test is the possibility of obtaining the results during 1 working day, with a signifi cant reduction of technician time per sample. Although onychomycosis is not a life threatening infection, rapid diagnosis may contribute to greater favourable outcomes. In countries where antifungal treatment is initiated on the basis of microscopic and/or culture positive results, treatment may be delayed in cases that are culture positive but microscopically negative (8% of positive cases, 3% of all Maiken Cavling Arendrup has received honoraries for speaking, consultancy, advisory board membership, or reimbursement of travel expenses from Merck Sharp and Dohme, Pfi zer, Scheering Plough, Swedish Orphan, Astellas, Mycognostica, and SpePharm. Maiken Cavling Arendrup has received research funding although not for this project from Merck, Astellas and Pfi zer. Maiken Cavling Arendrup holds no stocks or shares, and owns no patents.
